Jin Yoon

Has grant

Associate Professor

The University of Texas Health Science Center at Houston
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Development of a Behavioral Economic Intervention to Reduce HIV Risk Behaviors

Open Date: 2024-09-15

Close Date: 2027-08-31

Grant: Close

Assessment of Pioglitazone to Address Stress Reactivity and Alcohol Use Disorder

Open Date: 2021-09-20

Close Date: 2024-08-31

Grant: Close

Effects of cocaine on eating by pigeons

Open Date: 2003-09-15

Close Date: 2005-09-14

Articles (20)

Background: Inhibitory control deficits are associated with cocaine use disorder (CUD) development and maintenance. Additionally, drug use and inhibitory control can be negatively affected by depressive symptoms, including somatic factors like sleep disturbance and fatigue. Aim: The current study assessed the relationship between inhibitory control and depressive symptoms among individuals initiating CUD treatment. We examined associations among anti-saccade response inhibition performance, total scores on the Beck Depression Inventory-II (BDI-II), and individual BDI-II items. Methods: N = 101 patients enrolled in a clinical trial for CUD completed drug-specific anti-saccade and depression (BDI-II) measures prior to treatment. Generalized linear models tested the associations of anti-saccade error rate with stimulus type (cocaine, neutral) and with BDI-II total score. Penalized regression then modeled the error rate among the entire set of BDI-II items to select the most relevant symptom correlates. Results: Anti-saccade error rates were higher on cocaine relative to neutral trials ( p < 0.001), confirming attentional bias. Error rates were positively associated with BDI-II total scores, controlling for demographic and recent cocaine use variables ( p < 0.001); this association did not differ by stimulus content ( p = 0.742). Among BDI-II items, Loss of Pleasure, Crying, Agitation, Changes in Sleeping Pattern, Concentration Difficulty, Tiredness, and Loss of Interest in Sex were retained by the penalized regression of error rates. Conclusions: Attentional bias was drug-specific, and overall error rates were strongly related to somatic factors underlying depression in CUD. The association between inhibitory control and depression in CUD may be driven by physiological symptomatology, including sleep impairment and fatigue. ClinicalTrials.gov: NCT02896712.

Year:

2026

Year:

2026

Year:

2026

Year:

2025

We examined factors influencing the intention of Black and Hispanic gay and bisexual men aged 18-34 years in Texas to discuss starting long-acting injectable pre-exposure prophylaxis (LAI-PrEP) with healthcare providers. Participants were recruited through geosocial apps and community locations, completed online surveys measuring attitudes, subjective norms, perceived behavioral control (Theory of Planned Behavior), internalized homophobia, medical mistrust, HIV risk, and medical mistrust. Among the final sample ( N = 190), 63.5% intended to discuss LAI-PrEP. Poisson regression models indicated that higher attitudinal concerns [adjusted prevalence ratio (aPR): 0.80, 95% confidence interval (CI): 0.70, 0.92; P < 0.01) and higher medical mistrust (aPR: 0.98, 95% CI: 0.97, 0.99; P = 0.01) were linked to lower prevalence of intentions. Seeing a doctor in the past 12 months was associated with higher prevalence of discussing LAI-PrEP (aPR: 1.46, 95% CI: 1.00, 2.13; P = 0.05). Addressing concerns and reducing discrimination are crucial for improving LAI-PrEP uptake in this population.

Year:

2025

Background Alcohol, tobacco, and cannabis are the most commonly used substances among young populations, often leading to polysubstance use, which correlates with problematic consumption and adverse health outcomes. The contextualized reinforcer pathology (CRP) model explains addictive behaviors through several constructs, including the following: drug demand, delay discounting (DD), and substance‐free and substance‐related reinforcement. Most previous studies have focused on a single CRP construct and the couse of only two substances. This study aimed to characterize three subgroups of young adults reporting past month use of alcohol only, alcohol + tobacco or cannabis, and alcohol + tobacco + cannabis, in terms of the three constituents of the CRP model. Methods Young adult students ( N = 1487) completed CRP measures including the Alcohol Purchase Task, the Delay Discounting Task (for monetary rewards), and an abbreviated version of the Adolescent Reinforcement Survey Schedule‐Substance Use Version (ARSS‐SUV). ANOVA, chi‐square, and Student's t ‐tests were conducted to analyze group differences in terms of the CRP model. Results Higher demand intensity ( p = 0.001) and reinforcement from substance‐related activities ( p < 0.001) significantly predicted using alcohol + cannabis + tobacco compared to alcohol only use. DD and some alcohol demand indices (i.e., O max , P max , breakpoint and elasticity) were not associated with any substance use pattern. Conclusions Findings suggest that polysubstance use may enhance reward from leisure and social activities. Individuals with high reinforcement from substance‐related activities or high alcohol demand should be delivered interventions promoting activities that are both reinforcing and serve as alternatives to substance use.

Year:

2025

Introduction Exposure to prescription opioids following traumatic injury can increase the risk of developing tolerance, persistent opioid use and opioid use disorder. The mechanisms underlying opioid tolerance or dependence are not well understood, and no biomarkers predict risk. Opioid exposure causes epigenetic modifications, including alterations in microRNA (miRNA) expression. Several miRNAs, which regulate synaptic plasticity, are hypothesised to underlie substance use disorders and influence µ-opioid receptor levels, modulating opioid tolerance. This project aims to develop a bio-behavioural signature to predict persistent opioid use and chronic pain up to 6 months post-discharge. Methods and analysis The study will use a prospective cohort design, enrolling 180 adult patients at a Level I Trauma Center who are prescribed opioids at discharge. Prospective data will be collected in the hospital and at 7 days and 1, 3 and 6 months post-discharge. Biological data (genotyping and miRNA levels) and clinical measures of opioid use, pain, pain sensitivity (EEG) and psychosocial functioning will be collected at each time point. Bayesian regression methods will be used to identify baseline clinical, genetic, epigenetic and psychosocial predictors of opioid use and pain outcomes at 6 months post-discharge. Growth mixture modelling will identify distinct subgroups with varying trajectories, followed by Bayesian hierarchical modelling to predict trajectory classification based on predictor variables. Ethics and dissemination plan Ethics approval for this study was obtained from the University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects (HSC-MS-24–0314). Findings will be disseminated in peer-reviewed scientific journals and at national and international conferences.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Chukwuemeka Okafor

Assistant Professor (tenure track)

University of Texas Health Science Center at San Antonio

UNITED STATES
View details

Steven Shoptaw

Professor

University of California, Los Angeles

UNITED STATES
View details

Alba, PhD González-Roz

Assistant Professor

University of Oviedo

SPAIN
View details

Gema Aonso-Diego

Universidad de Deusto

SPAIN
View details

Joy Schmitz

Professor

University of Texas John P and Katherine G McGovern Medical School

UNITED STATES
View details

John Harvin

Assistant Professor

University of Texas Medical School at Houston

UNITED STATES
View details

Ángel García-Pérez

University of Oviedo

SPAIN
View details

Sara Weidberg

Associate Professor

University of Oviedo

SPAIN
View details

Víctor Martínez Loredo

Profesor Ayudante Doctor

Universidad de Sevilla

SPAIN
View details

Michael Weaver

Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Michelle A Patriquin

Assistant Dean | John S. Dunn Distinguished Professor | Co-Director of Research

The University of Texas Health Science Center at Houston

UNITED STATES
View details